Research & Development

大香蕉视频大香蕉在线视频大香蕉在线影院人民日报海外版:现金 今天我们依然需要它


  劉徹听得清楚,不由得再次仰天大笑道︰“好啊,今日就讓朕試試幾位愛卿依仗殺奴立功的騎術。”   丑庸笑道︰“不偷吃奴婢怎麼能長得這麼胖。”大香蕉视频   曹襄道︰“知道!”大香蕉在线视频   “噢,你去吧,妾身就不去了,昨晚雲瑯通過大長秋給妾身帶話說,爆炸起來很危險。” 大香蕉在线影院   “怎麼不吃了,難得見你喜歡一樣東西。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo